IMDX 8-K 2026-09-21

Insight Molecular Diagnostics Inc. (IMDX) 8-K dated 2026-09-21 — accession 0001493152-26-043560. This URL is the filing, not the IMDX hub.

Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.

Insight Molecular Diagnostics Inc. filed a 8-K on 2026-09-21. Accession 0001493152-26-043560.

Cached items: 1.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported IMDX revenue for 2025-12-31 was $4.1M. Net income was -$50.2M. Revenue was up 115.6% from 2024-12-31 to 2025-12-31. IMDX currently screens at market cap $117.1M.

Not investment advice. The IMDX SEC hub lists recent forms. The stock page is the research view.